Search

Author/Creator Luther, James M.

1. 418 Activation of the Glucagon-Like Peptide-1 Pathway in Obese Pre-Diabetic Individuals Improves Endothelial Function Independently of Weight Loss. (April 2022)

Authors:
Mashayekhi, Mona; Beckman, Joshua A.; Garner, Erica M.; Nian, Hui; Yu, Chang; Howard, Sara E.; Perkins, Bradley; Devin, Jessica K.; Koethe, John R.; Brown, Jonathan D.; Silver, Heidi; Luther, James M.; Brown, Nancy J.
Journal:
Journal of clinical and translational science
Issue:
Volume 6(2022)Supplement 1
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program. Issue 2 (21st June 2021)

Authors:
Akwo, Elvis A.; Robinson-Cohen, Cassianne; Chung, Cecilia P.; Shah, Shailja C.; Brown, Nancy J.; Ikizler, T. Alp; Wilson, Otis D.; Rowan, Bryce X.; Shuey, Megan M.; Siew, Edward D.; Luther, James M.; Giri, Ayush; Hellwege, Jacklyn N.; Velez Edwards, Digna R.; Roumie, Christianne L.; Tao, Ran; Tsa...
Journal:
Hypertension
Issue:
Volume 78:Issue 2(2021)
Page Start:
376
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Comparative effects of weight loss and incretin‐based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial. Issue 2 (10th November 2022)

Authors:
Mashayekhi, Mona; Beckman, Joshua A.; Nian, Hui; Garner, Erica M.; Mayfield, Dustin; Devin, Jessica K.; Koethe, John R.; Brown, Jonathan D.; Cahill, Katherine N.; Yu, Chang; Silver, Heidi; Niswender, Kevin; Luther, James M.; Brown, Nancy J.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 25:Issue 2(2023)
Page Start:
570
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Co‐Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine‐Associated Hypotension: A Retrospective Cohort Study. Issue 3 (18th October 2018)

Authors:
Chaugai, Sandip; Dickson, Alyson L.; Shuey, Megan M.; Feng, QiPing; Barker, Katherine A.; Wei, Wei‐Qi; Luther, James M.; Stein, C. Michael; Chung, Cecilia P.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 105:Issue 3(2019)
Page Start:
703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Early urine electrolyte patterns in patients with acute heart failure. (8th October 2018)

Authors:
Collins, Sean P.; Jenkins, Cathy A.; Baughman, Adrienne; Miller, Karen F.; Storrow, Alan B.; Han, Jin H.; Brown, Nancy J.; Liu, Dandan; Luther, James M.; McNaughton, Candace D.; Self, Wesley H.; Peng, Dungeng; Testani, Jeffrey M.; Lindenfeld, JoAnn
Journal:
ESC heart failure
Issue:
Volume 6:Number 1(2019)
Page Start:
80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks. Issue 4 (April 2019)

Authors:
Nanba, Kazutaka; Omata, Kei; Gomez-Sanchez, Celso E.; Stratakis, Constantine A.; Demidowich, Andrew P.; Suzuki, Mari; Thompson, Lester D. R.; Cohen, Debbie L.; Luther, James M.; Gellert, Lan; Vaidya, Anand; Barletta, Justine A.; Else, Tobias; Giordano, Thomas J.; Tomlins, Scott A.; Rainey, Willia...
Journal:
Hypertension
Issue:
Volume 73:Issue 4(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Glucagon‐like peptide‐1 receptor agonist use is associated with lower serum periostin. Issue 4 (17th January 2023)

Authors:
Foer, Dinah; Beeler, Patrick E.; Cui, Jing; Snyder, William E.; Mashayekhi, Mona; Nian, Hui; Luther, James M.; Karlson, Elizabeth W.; Boyce, Joshua A.; Cahill, Katherine N.
Journal:
Clinical & experimental allergy
Issue:
Volume 53:Issue 4(2023)
Page Start:
469
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans. Issue 4 (30th August 2021)

Authors:
Luther, James M.; Ray, Justina; Wei, Dawei; Koethe, John R.; Hannah, Latoya; DeMatteo, Anthony; Manning, Robert; Terker, Andrew S.; Peng, Dungeng; Nian, Hui; Yu, Chang; Mashayekhi, Mona; Gamboa, Jorge; Brown, Nancy J.
Journal:
Hypertension
Issue:
Volume 78:Issue 4(2021)
Page Start:
1092
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗